Monday, June 15, 2026

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

THE DEATH OF GOOGLE MAPS: Trump’s Brutal Tariffs Suffocate Tech Giants Over Stolen Korean Military Secrets

U.S. pressure on South Korea regarding high-precision map exports raises security concerns and potential discrimination against local firms.

Tag: Epyztek

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Top News

- Our Sponsors Ad -

Follow us